We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-11.4%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$57.4B
AUM Growth
-$7.29B
Cap. Flow
+$861M
Cap. Flow %
1.5%
Top 10 Hldgs %
21.3%
Holding
3,843
New
205
Increased
1,398
Reduced
1,819
Closed
309

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$368M
2
CSCO icon
Cisco
CSCO
+$131M
3
WMT icon
Walmart Inc
WMT
+$109M
4
VOO icon
Vanguard S&P 500 ETF
VOO
+$93.1M
5
IWD icon
iShares Russell 1000 Value ETF
IWD
+$87.2M

Top Sells

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$124M
2
PX
Praxair Inc
PX
+$110M
3
KHC icon
Kraft Heinz
KHC
+$86.3M
4
XNTK icon
State Street SPDR NYSE Technology ETF
XNTK
+$67.4M
5
PSA icon
Public Storage
PSA
+$56.7M

Sector Composition

Rank Sector Weight
1 Technology 9.78%
2 Financials 8.85%
3 Healthcare 8.68%
4 Industrials 6.29%
5 Consumer Discretionary 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PEGA icon
2351
Pegasystems
PEGA
$5.51B
$652K ﹤0.01%
27,254
-2,452
-8% -$64.3K
NRO
2352
Neuberger Real Estate Securities Income Fund Inc
NRO
$189M
$651K ﹤0.01%
164,347
+97,921
+147% +$427K
HAIN icon
2353
Hain Celestial
HAIN
$53.9M
$650K ﹤0.01%
40,960
+16,293
+66% +$363K
LMAT icon
2354
LeMaitre Vascular
LMAT
$1.87B
$650K ﹤0.01%
27,496
+2,201
+9% +$60.1K
PDN icon
2355
Invesco FTSE RAFI Developed Markets ex-US Small-Mid ETF
PDN
$367M
$649K ﹤0.01%
23,565
-15,695
-40% -$463K
TNDM icon
2356
Tandem Diabetes Care
TNDM
$1.61B
$648K ﹤0.01%
17,077
+10,075
+144% +$356K
BICK
2357
DELISTED
First Trust BICK Index Fund
BICK
$648K ﹤0.01%
26,186
-21,259
-45% -$535K
WBT
2358
DELISTED
Welbilt, Inc.
WBT
$648K ﹤0.01%
58,311
-46,780
-45% -$722K
CBAY
2359
DELISTED
Cymabay Therapeutics
CBAY
$647K ﹤0.01%
82,205
+5,899
+8% +$56.1K
MRK icon
2360
CALL
Merck
MRK
$334B
$646K ﹤0.01%
184,762
-14,672
-7% -$1.04M
EDIT icon
2361
Editas Medicine
EDIT
$432M
$645K ﹤0.01%
28,346
-5,432
-16% -$148K
PCG icon
2362
PG&E
PCG
$38.5B
$645K ﹤0.01%
27,171
-61,679
-69% -$2.21M
AWP
2363
abrdn Global Premier Properties Fund
AWP
$364M
$643K ﹤0.01%
43,035
-10,810
-20% -$178K
BC icon
2364
Brunswick
BC
$5.29B
$642K ﹤0.01%
13,830
-13,375
-49% -$715K
OPK icon
2365
Opko Health
OPK
$1.04B
$642K ﹤0.01%
213,190
-41,200
-16% -$140K
MVF
2366
DELISTED
BlackRock MuniVest Fund
MVF
$641K ﹤0.01%
77,548
+17,957
+30% +$151K
FRME icon
2367
First Merchants
FRME
$2.72B
$640K ﹤0.01%
18,673
+6,037
+48% +$245K
NHC icon
2368
National Healthcare
NHC
$3.44B
$639K ﹤0.01%
8,139
+1,416
+21% +$111K
MEN
2369
DELISTED
Blackrock Muni Enhanced Fund, Inc.
MEN
$639K ﹤0.01%
64,571
+201
+0.3% +$1.98K
CRESY
2370
Cresud
CRESY
$752M
$638K ﹤0.01%
56,127
-1,471
-3% -$16.3K
DIV icon
2371
Global X SuperDividend US ETF
DIV
$780M
$637K ﹤0.01%
28,427
+1,453
+5% +$35.2K
AMRX icon
2372
Amneal Pharmaceuticals
AMRX
$6.02B
$635K ﹤0.01%
46,935
-11,860
-20% -$214K
CLH icon
2373
Clean Harbors
CLH
$16.9B
$634K ﹤0.01%
12,846
+693
+6% +$43.2K
SRT
2374
DELISTED
Startek Inc.
SRT
$633K ﹤0.01%
95,129
-3,175
-3% -$19.7K
BHVN
2375
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$633K ﹤0.01%
17,111
-239
-1% -$8.62K
93 94
95
96 97

Similar funds

RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
PI
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return
ECU
Eisler Capital (UK) London, United Kingdom $21.7B AUM 0.34% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
AA
Axiom Advisory San Diego, California $10.7B AUM 25.51% 1-Year Est. Return
SA
SpiderRock Advisors Wilimington, Delaware $6.29B AUM
WPL
Winder Pte Ltd Singapore $5.59B AUM 41.5% 1-Year Est. Return
ECU
Eisler Capital (US) New York $4.67B AUM 35.2% 1-Year Est. Return

Raymond James & Associates's Q4 2018 Portfolio in Review

As of Q4 2018, Raymond James & Associates held 3,843 positions worth $57.4B, down 11% from $64.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q4 2018 filing shows 205 new, 1,398 increased, 1,819 reduced and 309 closed positions. Its largest new stake was Linde: 549,404 shares worth $87.1M. The largest sale was Oracle, an estimated $124M.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, down from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q4 2018 buy was Linde: 549,404 shares worth $87.1M.
  • Raymond James & Associates added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $368M increase.
  • Raymond James & Associates's biggest Q4 2018 reduction was Oracle, cutting an estimated $124M.
  • Raymond James & Associates fully exited Praxair Inc in Q4 2018, selling an estimated $110M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $57.4B portfolio in Q4 2018.
  • Raymond James & Associates opened 205 new positions and closed 309 in Q4 2018.
  • Raymond James & Associates's portfolio value fell 11% quarter-over-quarter to $57.4B.

Based on Raymond James & Associates's 13F filing for Q4 2018, filed 11 Feb 2019.